VYNE Therapeutics Inc (VYNE)

[tdeck]

That is okay, but, I am still awaiting HC Wainwright analyst Ram Selvaraju who actually covered Foamix and had a PT of $11 weigh in.

Analysts know companies and everything about that company and the other 30 they cover in a sector for a firm like Wainright.

H.C. Wainwright analyst Oscar (Oren) Livant who covered Menlo and lowered the target he had for Menlo and Seroplant from $8 to $2 now ups it to $2.50 maintaining his buy rating after the ER is valuing it on cash alone, nothing else as he hasn't a clue about Foamix nor should he.

Doesn't bum me out, but I am still awaiting the Foamix analysts to give their .02 cents. And, they are coming soon, whether before or after approval I haven't a clue but when the Foamix analyst speak that's when this flips a switch and gets normal.

Peace out.